Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2022-06-24 00:00:00 ET · period of report 2022-06-22 · accession 0000899243-22-023977 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-24 | 2022-06-22 | TCRT | Weis Holger | Dir | A - Grant | $0.00 | +40.0K | 160.2K | +33% | $0 |
| D | 2022-06-24 | 2022-06-22 | TCRT | Weis Holger | Dir | A - Grant | $0.00 | +100.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-22 | A | A | 40,000 | $0.00 | 160,167 | D | — | — | (F1) Includes 30,000 shares held in a joint account by the Reporting Person and his spouse. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-06-22 | A | A | 100,000 | $0.00 | 100,000 | D | $0.82 · — to 2032-06-21 | 100,000 Common Stock | (F2) The option vests in twelve equal monthly installments beginning on July 13, 2022. |